A Masked, Randomized, Phase 3 Comparison of Triple Fixed-Combination Bimatoprost/Brimonidine/Timolol versus Fixed-Combination Brimonidine/Timolol for Lowering Intraocular Pressure

Table 3

Responder analyses: percentage reduction in IOP from baseline and mean IOP levels achieved^a.

	Patients, n (%)		value
	TFC	DFC
IOP reduction at week 12
≥40%	[]	[]
	47 (54.7)	30 (34.9)	0.014
≥50%	[]	[]
	13 (15.1)	6 (7.0)	0.143
IOP level at week 12
≤13 mmHg	[]	[]
	29 (33.7)	13 (14.8)	0.004
≤12 mmHg	[]	[]
	14 (16.3)	4 (4.5)	0.013

DFC: dual fixed-combination; IOP: intraocular pressure; TFC: triple fixed-combination. ^aPerformed post hoc.